Medical Mindfulness: Virtual Reality Mindfulness Therapy for Anxiety and Pain Management in Patients With Acute and Chronic Pain
Launched by STANFORD UNIVERSITY · Aug 26, 2020
Trial Information
Current as of September 06, 2025
Suspended
Keywords
ClinConnect Summary
Inpatient: Inpatients will be presented with an informed consent. If they sign the consent, they will then be given a VR headset pre- programmed with content that they may use for the duration of their stay. GI patients headsets will be collected when they are discharged. There are pain and anxiety analog scales at the end of each program. This data will be downloaded to Stanford. Patient's will not be entering their PHI. we will know who has headsets, as they will be numbered. Patient who are hospitalized for chronic pain will be allowed to take the VR headset home for month and be asked t...
Gender
ALL
Eligibility criteria
- • Identify inclusion criteria.
- Participants must:
- • 1. be between ages of 5-80 years of age
- • 2. have comprehension of instructions in the English language
- • 3. English speaking
- • 4. Must be able to comprehend ICF
- • 5. Have a medical appointment or procedure at Stanford/LPCH (inpatient or outpatient) that may cause pain or anxiety.
- • Identify exclusion criteria.
- General Exclusion Criteria are as follows:
- • 1. Significant cognitive impairment/developmental delays
- • 2. Seizure Disorder
- • 3. history of motion sickness with virtual reality
- • 4. severe visual impairment
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
Patients applied
Trial Officials
Linda Nguyen, MD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials